What does the genetic evidence say about postpartum psychosis versus bipolar disorder?
The strongest genetic study among these papers directly compared the DNA of 176 women with postpartum psychosis to women with bipolar disorder and healthy controls. It found that women with postpartum psychosis had a 2.6 times higher genetic risk score for bipolar disorder compared to healthy women, and critically, they had a 1.4 to 1.5 times higher genetic risk score for bipolar disorder than women who actually had bipolar disorder [2]. This means the genetic architecture of postpartum psychosis is not identical to bipolar disorder—it carries an even heavier load of bipolar-related genes, suggesting it is a genetically distinct subtype.
A separate expert consensus panel, reviewing all available evidence, concluded that postpartum psychosis has a 'unique risk architecture, partly shared with bipolar disorder' and recommended it be classified as a distinct category within the bipolar disorders chapter of the DSM [4]. The panel noted that while most women with postpartum psychosis have prominent mood symptoms, the condition's rapid onset, specific timing after childbirth, and excellent response to lithium and electroconvulsive therapy set it apart from typical bipolar disorder [4].
How do immune system changes separate postpartum psychosis from bipolar disorder?
Beyond genetics, the biology of the immune system during the postpartum period provides another layer of distinction. Normally, after childbirth, a woman's body experiences a rapid surge in T-cells (a type of white blood cell) and a mild activation of the monocyte/macrophage system. In women with postpartum psychosis, this T-cell surge is blunted, and there is a greater increase in low-grade inflammation, including higher levels of pro-inflammatory cytokines [5]. These specific immune dysregulations are not characteristic of bipolar disorder outside the postpartum period, suggesting that the trigger for the episode is a unique interaction between the postpartum hormonal and immune environment and a woman's underlying vulnerability [5].
Why does this distinction matter for treatment and prevention?
Recognizing postpartum psychosis as biologically distinct has direct practical consequences. A meta-analysis of 37 studies found that women with a history of isolated postpartum psychosis have a 29% risk of a severe episode after a subsequent delivery, compared to a 17% risk for women with bipolar disorder [3]. This higher risk means that for women with a history of postpartum psychosis, starting preventive medication immediately after delivery—rather than during pregnancy—can minimize relapse risk while avoiding fetal exposure to medication [3]. This is a different strategy than for many women with bipolar disorder, who may need to continue medication throughout pregnancy.
Furthermore, because about half of first-onset postpartum psychosis cases are also the first onset of bipolar disorder, correctly diagnosing the episode as postpartum psychosis (rather than just 'bipolar disorder') allows clinicians to plan for long-term monitoring and future pregnancy planning [4]. The distinct biology also opens the door to potential new treatments targeting the immune system, such as anti-inflammatory agents or T-cell boosting therapies, which are being investigated specifically for postpartum mood disorders [5].
About These Sources
This answer is built on 5 peer-reviewed studies — published from 2016 to 2026, 2 from 2024 or later, 2 in Q1 journals — selected as the most relevant from 5 studies that passed quality screening, drawn from 52 papers retrieved from a database of over 500 million.
Sources used in this answer
Special Report: Women’s Reproductive Mental Health—A Clinical Framework
This clinical framework article notes that postpartum psychosis is a psychiatric emergency with onset within 4 weeks of delivery, and that it is closely linked to bipolar disorder, though a minority of women have episodes only in the postpartum period without underlying bipolar disorder.
More bipolar than bipolar disorder – a polygenic risk score analysis of postpartum psychosis
In a genetic study of 176 postpartum psychosis cases, women with the condition had significantly higher polygenic risk scores for bipolar disorder than both healthy controls (odds ratio 2.6) and women with bipolar disorder (odds ratio 1.4-1.5), suggesting a distinct genetic architecture.
Risk of Postpartum Relapse in Bipolar Disorder and Postpartum Psychosis: A Systematic Review and Meta-Analysis.
This meta-analysis of 37 studies found that women with a history of postpartum psychosis had a 29% risk of severe postpartum relapse, higher than the 17% risk for women with bipolar disorder, and that prophylactic medication after delivery is highly protective.
Postpartum Psychosis and Bipolar Disorder: Review of Neurobiology and Expert Consensus Statement on Classification
An expert consensus panel concluded that postpartum psychosis has a unique risk architecture partly shared with bipolar disorder, and recommended it be classified as a distinct category within the bipolar disorders chapter of the DSM, citing its distinct onset, treatment response, and prognosis.
Conventional and new immunotherapies for immune system dysregulation in postpartum mood disorders: comparisons to immune system dysregulations in bipolar disorder, major depression and postpartum autoimmune thyroid disease
This review found that postpartum psychosis is characterized by a blunted T-cell surge and increased low-grade inflammation (higher pro-inflammatory cytokines), immune dysregulations that are distinct from those seen in bipolar disorder outside the postpartum period.